PREDICTION MODEL OF ANEMIA USING ITPA GENOTYPE IDENTIFIES PATIENTS AT HIGH RISK OF ANEMIA AND TREATMENT FAILURE WITH PEGYLATED-INTERFERON PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C

被引：0
|
作者：
Kurosaki, M. [1 ]
Itakura, J. [1 ]
Tsuchiya, K. [1 ]
Nakanishi, H. [1 ]
Asahina, Y. [1 ]
Mizokami, M. [2 ]
Tanaka, Y. [3 ]
Izumi, N. [1 ]
机构：
[1] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan
[2] Res Ctr Hepatitis & Immunol, Chiba, Japan
[3] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
10.1016/S0168-8278(12)61140-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1128
引用
收藏
页码：S445 / S445
页数：1
相关论文
共 50 条
  • [1] Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated-interferon plus ribavirin therapy for chronic hepatitis C
    Kurosaki, Masayuki
    Tanaka, Yasuhito
    Nishida, Nao
    Sakamoto, Naoya
    Enomoto, Nobuyuki
    Matsuura, Kentaro
    Asahina, Yasuhiro
    Nakagawa, Mina
    Watanabe, Mamoru
    Sakamoto, Minoru
    Maekawa, Shinya
    Tokunaga, Katsushi
    Mizokami, Masashi
    Izumi, Namiki
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (03) : 449 - 458
  • [2] PREDICTION MODEL OF RIBAVIRIN-INDUCED ANEMIA INCORPORATING ITPA GENOTYPE COULD IDENTIFY CHRONIC HEPATITIS C PATIENTS AT HIGH RISK OF RELAPSE AMONG VIROLOGICAL RESPONDERS TO PEGYLATED-INTERFERON AND RIBAVIRIN
    Kurosaki, Masayuki
    Itakura, Jun
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Takahashi, Yuka
    Asahina, Yasuhiro
    Tanaka, Yasuhito
    Mizokami, Masashi
    Sakamoto, Naoya
    Enomoto, Nobuyuki
    Izumi, Namiki
    HEPATOLOGY, 2011, 54 : 823A - 823A
  • [3] THE ITPA GENOTYPE CORRELATES WITH HEMOLYTIC ANEMIA AND OUTCOME AFTER TREATMENT WITH PEGYLATED-INTERFERON AND RIBAVIRIN IN GENOTYPE 1B CHRONIC HEPATITIS C
    Kurosaki, M.
    Tanaka, K.
    Suzuki, Y.
    Hoshioka, Y.
    Tamaki, N.
    Kato, T.
    Yasui, Y.
    Hosokawa, T.
    Ueda, K.
    Tsuchiya, K.
    Kuzuya, T.
    Nakanishi, H.
    Itakura, J.
    Takahashi, Y.
    Asahina, Y.
    Mizokami, M.
    Tanaka, Y.
    Sakamoto, N.
    Enomoto, N.
    Izumi, N.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S179 - S179
  • [4] Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients
    Abdel-Moneim, Adel
    Abood, Alaa
    Abdel-Gabaar, Mohamed
    Zanaty, Mohamed I.
    Ramadan, Mohamed
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 4 (03) : 191 - 196
  • [5] The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C
    Pouryasin, Mohammad
    Keshvari, Maryam
    Sharafi, Heidar
    Alavian, Seyed Moayed
    Behnava, Bita
    Alavian, Seyed Ehsan
    Pouryasin, Ali
    HEPATITIS MONTHLY, 2016, 16 (02)
  • [6] ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin
    Murakawa, Miyako
    Asahina, Yasuhiro
    Nagata, Hiroko
    Nakagawa, Mina
    Kakinuma, Sei
    Nitta, Sayuri
    Kawai-Kitahata, Fukiko
    Otani, Satoshi
    Kaneko, Shun
    Miyoshi, Masato
    Tsunoda, Tomoyuki
    Asano, Yu
    Sato, Ayako
    Itsui, Yasuhiro
    Azuma, Seishin
    Nouchi, Toshihiko
    Furumoto, Yohei
    Asano, Tooru
    Chuganji, Yoshimichi
    Tohda, Shuji
    Watanabe, Mamoru
    HEPATOLOGY RESEARCH, 2017, 47 (11) : 1212 - 1218
  • [7] ITPA polymorphisms are predictors of anemia but no contribution to outcomes in chronic hepatitis C patients who treated with interferon plus ribavirin
    Chi, Xiumei
    Wang, Mo-li
    Pan, Yu
    Jiang, Jing
    Yan, Hongqing
    Wu, Ruihong
    Wang, Xiaomei
    Niu, Junqi
    HEPATOLOGY, 2015, 62 : 800A - 800A
  • [8] Leukocyte interferon-α and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon
    Adinolfi, Luigi E.
    Durante-Mangoni, Emanuele
    Salzillo, Marta
    Marrone, Aldo
    Tripodi, Marie-Francoise
    Restivo, Luciano
    Merola, Antonietta
    Zampino, Rosa
    Ruggiero, Giuseppe
    INTERNAL AND EMERGENCY MEDICINE, 2009, 4 (06) : 485 - 490
  • [9] Leukocyte interferon-α and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon
    Luigi E. Adinolfi
    Emanuele Durante-Mangoni
    Marta Salzillo
    Aldo Marrone
    Marie-Francoise Tripodi
    Luciano Restivo
    Antonietta Merola
    Rosa Zampino
    Giuseppe Ruggiero
    Internal and Emergency Medicine, 2009, 4 : 485 - 490
  • [10] Effects of Host and virus related factors on Interferon-α plus ribavirin and Pegylated-interferon plus ribavirin treatment outcomes in Chronic Hepatitis C patients
    Akram, Madiha
    Idrees, Muhammad
    Zafar, Shamail
    Hussain, Abrar
    Butt, Sadia
    Afzal, Samia
    Rehman, Irshad-ur
    Liaqat, Ali
    Saleem, Sana
    Ali, Muhammad
    Butt, Azeem
    VIROLOGY JOURNAL, 2011, 8
12345